全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Use of Bacterial Artificial Chromosomes in Baculovirus Research and Recombinant Protein Expression: Current Trends and Future Perspectives

DOI: 10.5402/2012/628797

Full-Text   Cite this paper   Add to My Lib

Abstract:

The baculovirus expression system is one of the most successful and widely used eukaryotic protein expression methods. This short review will summarise the role of bacterial artificial chromosomes (BACS) as an enabling technology for the modification of the virus genome. For many years baculovirus genomes have been maintained in E. coli as bacterial artificial chromosomes, and foreign genes have been inserted using a transposition-based system. However, with recent advances in molecular biology techniques, particularly targeting reverse engineering of the baculovirus genome by recombineering, new frontiers in protein expression are being addressed. In particular, BACs have facilitated the propagation of disabled virus genomes that allow high throughput protein expression. Furthermore, improvement in the selection of recombinant viral genomes inserted into BACS has enabled the expression of multiprotein complexes by iterative recombineering of the baculovirus genome. 1. Baculovirus Protein Expression 1.1. Baculoviruses The Baculoviridae is a family of viruses with a circular dsDNA genome, ranging in size from 80?kb to 180?kb, that infect arthropods. Virus particles are rod-shaped, with a lipid envelope derived from the host cell. The family is divided into four genera, based on the comparison of a subset of core genes conserved between all baculoviruses [1, 2]. The viruses used for recombinant protein expression are Autographa californica multiple nucleopolyhedrosis virus(AcMNPV) and Bombyx mori nucleopolyhedrosis virus(BmNPV) and both are in the Alphabaculovirus genus. Both viruses are pathogens of the larval stages of lepidopteran species and have an infection cycle that involves ingestion and infection of the cells of the mid-gut, followed by systemic infection. In contrast to vertebrate herpesviruses, which have a similarly sized, circular DNA genome, and which are largely cryptic infections except in immunocompromised individuals, infection of caterpillars with AcMNPV and BmNPV results in a short duration, acute, systemic infection with liquefaction of the host (Figure 1). Once the host is liquefied, the virus remains in the environment encased in a protein matrix formed from the virally encoded polyhedrin protein until it is ingested by the next caterpillar and the alkali environment of the insect mid-gut triggers dissociation of the polyhedrin coat and release of the virus [3, 4]. Figure 1: Key stages in the infection cycle of AcMNPV. (A) Infection is initiated by the ingestion of a virus occlusion body (OB). This consists of multiple virus

References

[1]  J. A. Jehle, G. W. Blissard, B. C. Bonning et al., “On the classification and nomenclature of baculoviruses: a proposal for revision,” Archives of Virology, vol. 151, no. 7, pp. 1257–1266, 2006.
[2]  S. A. Miele, M. J. Garavaglia, M. N. Belaich, and P. D. Ghiringhelli, “Baculovirus: molecular insights on their diversity and conservation,” International Journal of Evolutionary Biology, vol. 2011, Article ID 379424, 15 pages, 2011.
[3]  L. E. Volkman and M. D. Summers, “Autographa californica nuclear polyhedrosis virus: comparative infectivity of the occluded, alkali-liberated, and nonoccluded forms,” Journal of Invertebrate Pathology, vol. 30, no. 1, pp. 102–103, 1977.
[4]  E. K. Engelhard, L. N. W. Kam-Morgan, J. O. Washburn, and L. E. Volkman, “The insect tracheal system: a conduit for the systemic spread of Autographa californica M nuclear polyhedrosis virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 8, pp. 3224–3227, 1994.
[5]  Z. Li and G. W. Blissard, “The pre-transmembrane domain of the Autographa californica multicapsid nucleopolyhedrovirus GP64 protein is critical for membrane fusion and virus infectivity,” Journal of Virology, vol. 83, no. 21, pp. 10993–11004, 2009.
[6]  J. T. Mangor, S. A. Monsma, M. C. Johnson, and G. W. Blissard, “A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein,” Journal of Virology, vol. 75, no. 6, pp. 2544–2556, 2001.
[7]  K. L. Hefferon, A. G. P. Oomens, S. A. Monsma, C. M. Finnerty, and G. W. Blissard, “Host cell receptor binding by baculovirus GP64 and kinetics of virion entry,” Virology, vol. 258, no. 2, pp. 455–468, 1999.
[8]  S. A. Monsma, A. G. P. Oomens, and G. W. Blissard, “The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection,” Journal of Virology, vol. 70, no. 7, pp. 4607–4616, 1996.
[9]  G. W. Blissard and J. R. Wenz, “Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion,” Journal of Virology, vol. 66, no. 11, pp. 6829–6835, 1992.
[10]  J. Kadlec, S. Loureiro, N. G. A. Abrescia, D. I. Stuart, and I. M. Jones, “The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines,” Nature Structural and Molecular Biology, vol. 15, no. 10, pp. 1024–1030, 2008.
[11]  M. D. Ayres, S. C. Howard, J. Kuzio, M. Lopez-Ferber, and R. D. Possee, “The complete DNA sequence of Autographa californica nuclear polyhedrosis virus,” Virology, vol. 202, no. 2, pp. 586–605, 1994.
[12]  K. L. W. Schultz, J. A. Wetter, D. C. Fiore, and P. D. Friesen, “Transactivator IE1 is required for baculovirus early replication events that trigger apoptosis in permissive and nonpermissive cells,” Journal of Virology, vol. 83, no. 1, pp. 262–272, 2009.
[13]  V. A. Olson, J. A. Wetter, and P. D. Friesen, “The highly conserved basic domain I of baculovirus IE1 is required for hr enhancer DNA binding and hr-dependent transactivation,” Journal of Virology, vol. 77, no. 10, pp. 5668–5677, 2003.
[14]  S. S. Pullen and P. D. Friesen, “The CAGT motif functions as an initiator element during early transcription of the baculovirus transregulator ie-1,” Journal of Virology, vol. 69, no. 6, pp. 3575–3583, 1995.
[15]  M. S. Nissen and P. D. Friesen, “Molecular analysis of the transcriptional regulatory region of an early baculovirus gene,” Journal of Virology, vol. 63, no. 2, pp. 493–503, 1989.
[16]  D. L. Jarvis, C. Weinkauf, and L. A. Guarino, “Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells,” Protein Expression and Purification, vol. 8, no. 2, pp. 191–203, 1996.
[17]  G. R. Kovacs, L. A. Guarino, and M. D. Summers, “Novel regulatory properties of the IE1 and IE0 transactivators encoded by the baculovirus Autographa californica multicapsid nuclear polyhedrosis virus,” Journal of Virology, vol. 65, no. 10, pp. 5281–5288, 1991.
[18]  D. L. Jarvis, J. A. G. W. Fleming, G. R. Kovacs, M. D. Summers, and L. A. Guarino, “Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells,” Nature Biotechnology, vol. 8, no. 10, pp. 950–955, 1990.
[19]  L. A. Guarino and M. D. Summers, “Functional mapping of a trans-activating gene required for expression of a baculovirus delayed-early gene,” Journal of Virology, vol. 57, no. 2, pp. 563–571, 1986.
[20]  S. S. Jiang, I. S. Chang, L. W. Huang et al., “Temporal transcription program of recombinant Autographa californica multiple nucleopolyhedrosis virus,” Journal of Virology, vol. 80, no. 18, pp. 8989–8999, 2006.
[21]  L. E. Volkman, M. D. Summers, and C. H. Hsieh, “Occluded and nonoccluded nuclear polyhedrosis virus grown in Trichoplusia ni: comparative neutralization, comparative infectivity, and in vitro growth studies,” Journal of Virology, vol. 19, no. 3, pp. 820–832, 1976.
[22]  M. Marek, M. M. van Oers, F. F. Devaraj, J. M. Vlak, and O. W. Merten, “Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals,” Biotechnology and Bioengineering, vol. 108, no. 5, pp. 1056–1067, 2011.
[23]  B. G. Ooi and L. K. Miller, “Regulation of host RNA levels during baculovirus infection,” Virology, vol. 166, no. 2, pp. 515–523, 1988.
[24]  I. Nobiron, D. R. O'Reilly, and J. A. Olszewski, “Autographa californica nucleopolyhedrovirus infection of Spodoptera frugiperda cells: a global analysis of host gene regulation during infection, using a differential display approach,” Journal of General Virology, vol. 84, no. 11, pp. 3029–3039, 2003.
[25]  T. Z. Salem, F. Zhang, Y. Xie, and S. M. Thiem, “Comprehensive analysis of host gene expression in Autographa californica nucleopolyhedrovirus-infected Spodoptera frugiperda cells,” Virology, vol. 412, no. 1, pp. 167–178, 2011.
[26]  H. Beniya, C. J. Funk, G. F. Rohrmann, and R. F. Weaver, “Purification of a virus-induced RNA polymerase from Autographa californica nuclear polyhedrosis virus-infected Spodoptera frugiperda cells that accurately initiates late and very late transcription in vitro,” Virology, vol. 216, no. 1, pp. 12–19, 1996.
[27]  C. L. Yang, D. A. Stetler, and R. F. Weaver, “Structural comparison of the Autographa californica nuclear polyhedrosis virus-induced RNA polymerase and the three nuclear RNA polymerases from the host, Spodoptera frugiperda,” Virus Research, vol. 20, no. 3, pp. 251–264, 1991.
[28]  N. E. Huh and R. F. Weaver, “Identifying the RNA polymerases that synthesize specific transcripts of the Autographa californica nuclear polyhedrosis virus,” Journal of General Virology, vol. 71, no. 1, pp. 195–201, 1990.
[29]  L. Y. Fuchs, M. S. Woods, and R. F. Weaver, “Viral transcription during Autographa californica nuclear polyhedrosis virus infection: a novel RNA polymerase induced in infected Spodoptera frugiperda cells,” Journal of Virology, vol. 48, no. 3, pp. 641–646, 1983.
[30]  A. L. Passarelli and L. A. Guarino, “Baculovirus late and very late gene regulation,” Current Drug Targets, vol. 8, no. 10, pp. 1103–1115, 2007.
[31]  D. Knebel-M?rsdorf, I. Quadt, Y. Li, L. Montier, and L. A. Guarino, “Expression of baculovirus late and very late genes depends on LEF-4, a component of the viral RNA polymerase whose guanyltransferase function is essential,” Journal of Virology, vol. 80, no. 8, pp. 4168–4173, 2006.
[32]  L. A. Guarino, B. Xu, J. Jin, and W. Dong, “A virus-encoded RNA polymerase purified from baculovirus-infected cells,” Journal of Virology, vol. 72, no. 10, pp. 7985–7991, 1998.
[33]  E. A. Crouch, L. T. Cox, K. G. Morales, and A. L. Passarelli, “Inter-subunit interactions of the Autographa californica M nucleopolyhedrovirus RNA polymerase,” Virology, vol. 367, no. 2, pp. 265–274, 2007.
[34]  L. K. Miller, A. J. Lingg, and L. A. Bulla, “Bacterial, viral, and fungal insecticides,” Science, vol. 219, no. 4585, pp. 715–721, 1983.
[35]  L. K. Miller, “Genetically engineered insect virus pesticides: present and future,” Journal of Invertebrate Pathology, vol. 65, no. 3, pp. 211–216, 1995.
[36]  A. B. Inceoglu, S. G. Kamita, A. C. Hinton, et al., “Recombinant baculoviruses for insect control,” Pest Management Science, vol. 57, no. 10, pp. 981–987, 2001.
[37]  B. Szewczyk, L. Hoyos-Carvajal, M. Paluszek, I. Skrzecz, and M. Lobo De Souza, “Baculoviruses—re-emerging biopesticides,” Biotechnology Advances, vol. 24, no. 2, pp. 143–160, 2006.
[38]  E. A. Crouch and A. L. Passarelli, “Genetic requirements for homologous recombination in Autographa californica nucleopolyhedrovirus,” Journal of Virology, vol. 76, no. 18, pp. 9323–9334, 2002.
[39]  D. W. Martin and P. C. Weber, “DNA replication promotes high-frequency homologous recombination during Autographa californica multiple nuclear polyhedrosis virus infection,” Virology, vol. 232, no. 2, pp. 300–309, 1997.
[40]  G. E. Smith, M. D. Summers, and M. J. Fraser, “Production of human beta interferon in insect cells infected with a baculovirus expression vector,” Molecular and Cellular Biology, vol. 3, no. 12, pp. 2156–2165, 1983.
[41]  G. D. Pennock, C. Shoemaker, and L. K. Miller, “Strong and regulated expression of Escherichia coli beta-galactosidase in insect cells with a baculovirus vector,” Molecular and Cellular Biology, vol. 4, no. 3, pp. 399–406, 1984.
[42]  P. A. Kitts, M. D. Ayres, and R. D. Possee, “Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors,” Nucleic Acids Research, vol. 18, no. 19, pp. 5667–5672, 1990.
[43]  D. Zuidema, E. C. Klinge-Roode, J. W. M. van Lent, and J. M. Vlak, “Construction and analysis of an Autographa californica nuclear polyhedrosis virus mutant lacking the polyhedral envelope,” Virology, vol. 173, no. 1, pp. 98–108, 1989.
[44]  J. Vialard, M. Lalumiere, T. Vernet et al., “Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the β-galactosidase gene,” Journal of Virology, vol. 64, no. 1, pp. 37–50, 1990.
[45]  J. M. Vlak, A. Schouten, M. Usmany et al., “Expression of cauliflower mosaic virus gene I using a baculovirus vector based upon the p10 gene and a novel selection method,” Virology, vol. 179, no. 1, pp. 312–320, 1990.
[46]  D. Zuidema, A. Schouten, M. Usmany et al., “Expression of cauliflower mosaic virus gene I in insect cells using a novel polyhedrin-based baculovirus expression vector,” Journal of General Virology, vol. 71, no. 10, pp. 2201–2209, 1990.
[47]  R. J. Noad, M. Stewart, M. Boyce, C. C. Celma, K. R. Willison, and P. Roy, “Multigene expression of protein complexes by iterative modification of genomic bacmid DNA,” BMC Molecular Biology, vol. 10, article 87, 2009.
[48]  P. T. Loudon, T. Hirasawa, S. Oldfield, M. Murphy, and P. Roy, “Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses,” Virology, vol. 182, no. 2, pp. 793–801, 1991.
[49]  T. J. French, J. J. A. Marshall, and P. Roy, “Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structure proteins,” Journal of Virology, vol. 64, no. 12, pp. 5695–5700, 1990.
[50]  T. J. French and P. Roy, “Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV,” Journal of Virology, vol. 64, no. 4, pp. 1530–1536, 1990.
[51]  B. Fuchs, D. Hecker, and K. H. Scheidtmann, “Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding,” European Journal of Biochemistry, vol. 228, no. 3, pp. 625–639, 1995.
[52]  H. Nyunoya, T. Akagi, T. Ogura, S. Maeda, and K. Shimotohno, “Evidence for phosphorylation of trans-activator p40(x) of human T-cell leukemia virus type 1 produced in insect cells with a baculovirus expression vector,” Virology, vol. 167, no. 2, pp. 538–544, 1988.
[53]  S. Maekawa, Y. Matsuura, and S. Nakamura, “Expression and myristoylation of NAP-22 using a baculovirus transfer vector system,” Biochimica et Biophysica Acta, vol. 1218, no. 1, pp. 119–122, 1994.
[54]  M. Kloc, B. Reddy, S. Crawford, and L. D. Etkin, “A novel 110-kDa maternal CAAX box-containing protein from Xenopus is palmitoylated and isoprenylated when expressed in baculovirus,” The Journal of Biological Chemistry, vol. 266, no. 13, pp. 8206–8212, 1991.
[55]  D. L. Jarvis and E. E. Finn, “Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells,” Virology, vol. 212, no. 2, pp. 500–511, 1995.
[56]  A. Hillar and D. L. Jarvis, “Re-visiting the endogenous capacity for recombinant glycoprotein sialylation by baculovirus-infected Tn-4h and DpN1 cells,” Glycobiology, vol. 20, no. 10, pp. 1323–1330, 2010.
[57]  R. L. Harrison and D. L. Jarvis, “Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce “mammalianized” recombinant glycoproteins,” Advances in Virus Research, vol. 68, pp. 159–191, 2006.
[58]  D. R. Hill, J. J. Aumiller, X. Shi, and D. L. Jarvis, “Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium,” Biotechnology and Bioengineering, vol. 95, no. 1, pp. 37–47, 2006.
[59]  V. A. Luckow, S. C. Lee, G. F. Barry, and P. O. Olins, “Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli,” Journal of Virology, vol. 67, no. 8, pp. 4566–4579, 1993.
[60]  K. J. Airenne, E. Peltomaa, V. P. Hyt?nen, O. H. Laitinen, and S. Yl?-Herttuala, “Improved generation of recombinant baculovirus genomes in Escherichia coli,” Nucleic acids research, vol. 31, no. 17, article e101, 2003.
[61]  G. P. Pijlman, J. C. F. M. Dortmans, A. M. G. Vermeesch et al., “Pivotal role of the non-hr origin of DNA replication in the genesis of defective interfering baculoviruses,” Journal of Virology, vol. 76, no. 11, pp. 5605–5611, 2002.
[62]  H. Wang, F. Deng, G. P. Pijlman et al., “Cloning of biologically active genomes from a Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus isolate by using a bacterial artificial chromosome,” Virus Research, vol. 97, no. 2, pp. 57–63, 2003.
[63]  O. Simón, T. Williams, A. C. Asensio et al., “Sf29 gene of Spodoptera frugiperda multiple nucleopolyhedrovirus is a viral factor that determines the number of virions in occlusion bodies,” Journal of Virology, vol. 82, no. 16, pp. 7897–7904, 2008.
[64]  Y. Miao, Y. Zhang, K. Nakagaki et al., “Expression of spider flagelliform silk protein in Bombyx mori cell line by a novel Bac-to-Bac/BmNPV baculovirus expression system,” Applied Microbiology and Biotechnology, vol. 71, no. 2, pp. 192–199, 2006.
[65]  K. A. Datsenko and B. L. Wanner, “One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6640–6645, 2000.
[66]  E. B. Carstens, H. Chan, H. Yu, G. V. Williams, and R. Casselman, “Genetic analyses of temperature-sensitive mutations in baculovirus late expression factors,” Virology, vol. 204, no. 1, pp. 323–337, 1994.
[67]  S. Partington, H. Yu, A. Lu, and E. B. Carstens, “Isolation of temperature sensitive mutants of Autographa californica nuclear polyhedrosis virus: phenotype characterization of baculovirus mutants defective in very late gene expression,” Virology, vol. 175, no. 1, pp. 91–102, 1990.
[68]  G. Liu and E. B. Carstens, “Site-directed mutagenesis of the AcMNPV p 143 gene: effects on baculovirus DNA replication,” Virology, vol. 253, no. 1, pp. 125–136, 1999.
[69]  C. J. Thomas, G. W. Gooday, L. A. King, and R. D. Possee, “Mutagenesis of the active site coding region of the Autographa californica nucleopolyhedrovirus chiA gene,” Journal of General Virology, vol. 81, no. 5, pp. 1403–1411, 2000.
[70]  G. Lin and G. W. Blissard, “Analysis of an Autographa californica nucleopolyhedrovirus lef-11 knockout: Lef-11 is essential for viral DNA replication,” Journal of Virology, vol. 76, no. 6, pp. 2770–2779, 2002.
[71]  D. K. Bideshi and B. A. Federici, “The Trichoplusia ni granulovirus helicase in unable to support replication of Autographa californica multicapsid nucleopolyhedrovirus in cells and larvae of T. ni,” Journal of General Virology, vol. 81, no. 6, pp. 1593–1599, 2000.
[72]  N. Takahashi, H. Yoshikura, and I. Kobayashi, “An Escherichia coli strain, BJ5183, that shows highly efficient conservative (two-progeny) DNA double-strand break repair of restriction breaks,” Gene, vol. 303, no. 1-2, pp. 89–97, 2003.
[73]  H. Shen, K. Chen, Q. Yao et al., “Characterization of Bombyx mori nucleopolyhedrovirus orf74, a novel gene involved in virulence of virus,” Virus Genes, vol. 38, no. 3, pp. 487–494, 2009.
[74]  J. Huang, B. Hao, F. Deng, X. Sun, H. Wang, and Z. Hu, “Open reading frame Bm21 of Bombyx mori nucleopolyhedrovirus is not essential for virus replication in vitro, but its deletion extends the median survival time of infected larvae,” Journal of General Virology, vol. 89, no. 4, pp. 922–930, 2008.
[75]  Y. Wang, N. Sathish, C. Hollow, and Y. Yuan, “Functional characterization of Kaposi's sarcoma-associated herpesvirus open reading frame K8 by bacterial artificial chromosome-based mutagenesis,” Journal of Virology, vol. 85, no. 5, pp. 1943–1957, 2011.
[76]  N. Sathish and Y. Yuan, “Functional characterization of Kaposi's sarcoma-associated herpesvirus small capsid protein by bacterial artificial chromosome-based mutagenesis,” Virology, vol. 407, no. 2, pp. 306–318, 2010.
[77]  F. X. Zhu, X. Li, F. Zhou, S. J. Gao, and Y. Yuan, “Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis,” Journal of Virology, vol. 80, no. 24, pp. 12187–12196, 2006.
[78]  H. Yao, N. Osterrieder, and D. J. O'Callaghan, “Generation and characterization of an EICP0 null mutant of equine herpesvirus 1,” Virus Research, vol. 98, no. 2, pp. 163–172, 2003.
[79]  L. Petherbridge, K. Howes, S. J. Baigent et al., “Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines,” Journal of Virology, vol. 77, no. 16, pp. 8712–8718, 2003.
[80]  S. Trapp, N. Osterrieder, G. M. Keil, and M. Beer, “Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants,” Journal of General Virology, vol. 84, no. 2, pp. 301–306, 2003.
[81]  B. K. Tischer, B. B. Kaufer, M. Sommer, F. Wussow, A. M. Arvin, and N. Osterrieder, “A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9,” Journal of Virology, vol. 81, no. 23, pp. 13200–13208, 2007.
[82]  P. Rueda, J. Fominaya, J. P. M. Langeveld, C. Bruschke, C. Vela, and J. I. Casal, “Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles,” Vaccine, vol. 19, no. 7-8, pp. 726–734, 2000.
[83]  F. M. Boyce and N. L. R. Bucher, “Baculovirus-mediated gene transfer into mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 6, pp. 2348–2352, 1996.
[84]  L. F. Carbonell and L. K. Miller, “Baculovirus interaction with nontarget organisms: a virus-borne reporter gene is not expressed in two mammalian cell lines,” Applied and Environmental Microbiology, vol. 53, no. 7, pp. 1412–1417, 1987.
[85]  M. Marek, O. W. Merten, L. Galibert, J. M. Vlak, and M. M. van Oers, “Baculovirus VP80 protein and the F-actin cytoskeleton interact and connect the viral replication factory with the nuclear periphery,” Journal of Virology, vol. 85, no. 11, pp. 5350–5362, 2011.
[86]  V. A. Luckow, “Baculovirus systems for the expression of human gene products,” Current Opinion in Biotechnology, vol. 4, no. 5, pp. 564–572, 1993.
[87]  G. P. Pijlman, J. E. van Schinjndel, and J. M. Vlak, “Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells,” Journal of General Virology, vol. 84, no. 10, pp. 2669–2678, 2003.
[88]  G. P. Pijlman, J. de Vrij, F. J. van den End, J. M. Vlak, and D. E. Martens, “Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect-cell bioreactors,” Biotechnology and Bioengineering, vol. 87, no. 6, pp. 743–753, 2004.
[89]  G. P. Pijlman, E. C. Roode, X. Fan et al., “Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript,” Journal of Biotechnology, vol. 123, no. 1, pp. 13–21, 2006.
[90]  P. A. Kitts and R. D. Possee, “A method for producing recombinant baculovirus expression vectors at high frequency,” BioTechniques, vol. 14, no. 5, pp. 810–817, 1993.
[91]  Y. Zhao, D. A. Chapman, and I. M. Jones, “Improving baculovirus recombination,” Nucleic Acids Research, vol. 31, no. 2, article E6, 2003.
[92]  R. B. Hitchman, R. D. Possee, A. T. Crombie et al., “Genetic modification of a baculovirus vector for increased expression in insect cells,” Cell Biology and Toxicology, vol. 26, no. 1, pp. 57–68, 2010.
[93]  R. B. Hitchman, R. D. Possee, and L. A. King, “Baculovirus expression systems for recombinant protein production in insect cells,” Recent Patents on Biotechnology, vol. 3, no. 1, pp. 46–54, 2009.
[94]  A. L. Vanarsdall, V. S. Mikhailov, and G. F. Rohrmann, “Characterization of a baculovirus lacking the DBP (DNA-binding protein) gene,” Virology, vol. 364, no. 2, pp. 475–485, 2007.
[95]  M. Yu and E. B. Carstens, “Identification of a domain of the baculovirus Autographa californica multiple nucleopolyhedrovirus single-strand DNA-binding protein LEF-3 essential for viral DNA replication,” Journal of Virology, vol. 84, no. 12, pp. 6153–6162, 2010.
[96]  J. Su, O. Lung, and G. W. Blissard, “The Autographa californica multiple nucleopolyhedrovirus lef-5 gene is required for productive infection,” Virology, vol. 416, no. 1-2, pp. 54–64, 2011.
[97]  G. Lin and G. W. Blissard, “Analysis of an Autographa californica multicapsid nucleopolyhedrovirus lef-6-null virus: LEF-6 is not essential for viral replication but appears to accelerate late gene transcription,” Journal of Virology, vol. 76, no. 11, pp. 5503–5514, 2002.
[98]  K. Okano, A. L. Vanarsdall, and G. F. Rohrmann, “Characterization of a baculovirus lacking the alkaline nuclease gene,” Journal of Virology, vol. 78, no. 19, pp. 10650–10656, 2004.
[99]  K. Okano, A. L. Vanarsdall, and G. F. Rohrmann, “A baculovirus alkaline nuclease knockout construct produces fragmented DNA and aberrant capsids,” Virology, vol. 359, no. 1, pp. 46–54, 2007.
[100]  A. L. Vanarsdall, K. Okano, and G. F. Rohrmann, “Characterization of the replication of a baculovirus mutant lacking the DNA polymerase gene,” Virology, vol. 331, no. 1, pp. 175–180, 2005.
[101]  T. M. Stewart, I. Huijskens, L. G. Willis, and D. A. Theilmann, “The Autographa californica multiple nucleopolyhedrovirus ie0-ie1 gene complex is essential for wild-type virus replication, but either IE0 or IE1 can support virus growth,” Journal of Virology, vol. 79, no. 8, pp. 4619–4629, 2005.
[102]  O. Y. Lung, M. Cruz-Alvarez, and G. W. Blissard, “Ac23, an envelope fusion protein homolog in the baculovirus Autographa californica multicapsid nucleopolyhedrovirus, is a viral pathogenicity factor,” Journal of Virology, vol. 77, no. 1, pp. 328–339, 2003.
[103]  O. Lung, M. Westenberg, J. M. Vlak, D. Zuidema, and G. W. Blissard, “Pseudotyping Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV): F proteins from group II NPVs are functionally analogous to AcMNPV GP64,” Journal of Virology, vol. 76, no. 11, pp. 5729–5736, 2002.
[104]  M. Fang, Y. Nie, S. Harris, M. A. Erlandson, and D. A. Theilmann, “Autographa californica multiple nucleopolyhedrovirus core gene ac96 encodes a per os infectivity factor (pif-4),” Journal of Virology, vol. 83, no. 23, pp. 12569–12578, 2009.
[105]  W. Zhou, L. Yao, H. Xu, F. Yan, and Y. Qi, “The function of envelope protein p74 from Autographa californica multiple nucleopolyhedrovirus in primary infection to host,” Virus Genes, vol. 30, no. 2, pp. 139–150, 2005.
[106]  M. Wang, E. Tuladhar, S. Shen et al., “Specificity of baculovirus P6.9 basic DNA-binding proteins and critical role of the C terminus in virion formation,” Journal of Virology, vol. 84, no. 17, pp. 8821–8828, 2010.
[107]  C. Liu, Z. Li, W. Wu et al., “Autographa californica multiple nucleopolyhedrovirus ac53 plays a role in nucleocapsid assembly,” Virology, vol. 382, no. 1, pp. 59–68, 2008.
[108]  A. L. Vanarsdall, K. Okano, and G. F. Rohrmann, “Characterization of the role of very late expression factor 1 in baculovirus capsid structure and DNA processing,” Journal of Virology, vol. 80, no. 4, pp. 1724–1733, 2006.
[109]  A. L. Vanarsdall, K. Okano, and G. F. Rohrmann, “Characterization of a baculovirus with a deletion of vlf-1,” Virology, vol. 326, no. 1, pp. 191–201, 2004.
[110]  W. Wu, T. Lin, L. Pan et al., “Autographa californica multiple nucleopolyhedrovirus nucleocapsid assembly is interrupted upon deletion of the 38K gene,” Journal of Virology, vol. 80, no. 23, pp. 11475–11485, 2006.
[111]  A. L. Vanarsdall, M. N. Pearson, and G. F. Rohrmann, “Characterization of baculovirus constructs lacking either the Ac 101, Ac 142, or the Ac 144 open reading frame,” Virology, vol. 367, no. 1, pp. 187–195, 2007.
[112]  L. Lin, J. Wang, R. Deng, J. Ke, H. Wu, and X. Wang, “ac109 is required for the nucleocapsid assembly of Autographa californica multiple nucleopolyhedrovirus,” Virus Research, vol. 144, no. 1-2, pp. 130–135, 2009.
[113]  M. Fang, X. Dai, and D. A. Theilmann, “Autographa californica multiple nucleopolyhedrovirus EXON0 (ORF141) is required for efficient egress of nucleocapsids from the nucleus,” Journal of Virology, vol. 81, no. 18, pp. 9859–9869, 2007.
[114]  X. Dai, T. M. Stewart, J. A. Pathakamuri, Q. Li, and D. A. Theilmann, “Autographa californica multiple nucleopolyhedrovirus exon0 (orf141), which encodes a RING finger protein, is required for efficient production of budded virus,” Journal of Virology, vol. 78, no. 18, pp. 9633–9644, 2004.
[115]  J. Ke, J. Wang, R. Deng, and X. Wang, “Autographa californica multiple nucleopolyhedrovirus ac66 is required for the efficient egress of nucleocapsids from the nucleus, general synthesis of preoccluded virions and occlusion body formation,” Virology, vol. 374, no. 2, pp. 421–431, 2008.
[116]  C. B. McCarthy, X. Dai, C. Donly, and D. A. Theilmann, “Autographa californica multiple nucleopolyhedrovirus ac142, a core gene that is essential for BV production and ODV envelopment,” Virology, vol. 372, no. 2, pp. 325–339, 2008.
[117]  M. Yuan, W. Wu, C. Liu et al., “A highly conserved baculovirus gene p48 (ac103) is essential for BV production and ODV envelopment,” Virology, vol. 379, no. 1, pp. 87–96, 2008.
[118]  Z. Hu, M. Yuan, W. Wu, C. Liu, K. Yang, and Y. Pang, “Autographa californica multiple nucleopolyhedrovirus ac76 is involved in intranuclear microvesicle formation,” Journal of Virology, vol. 84, no. 15, pp. 7437–7447, 2010.
[119]  Y. Nie, M. Fang, and D. A. Theilmann, “Autographa californica multiple nucleopolyhedrovirus core gene ac92 (p33) is required for efficient budded virus production,” Virology, vol. 409, no. 1, pp. 38–45, 2011.
[120]  J. de Jong, B. M. Arif, D. A. Theilmann, and P. J. Krell, “Autographa californica multiple nucleopolyhedrovirus me53 (ac140) is a nonessential gene required for efficient budded-virus production,” Journal of Virology, vol. 83, no. 15, pp. 7440–7448, 2009.
[121]  Y. Wang, W. Wu, Z. Li et al., “ac18 is not essential for the propagation of Autographa californica multiple nucleopolyhedrovirus,” Virology, vol. 367, no. 1, pp. 71–81, 2007.
[122]  T. Urakawa and P. Roy, “Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10,” Journal of Virology, vol. 62, no. 11, pp. 3919–3927, 1988.
[123]  P. T. Loudon and P. Roy, “Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like particles,” Virology, vol. 180, no. 2, pp. 798–802, 1991.
[124]  M. Stewart, Y. Bhatia, T. N. Athmaran et al., “Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus,” Vaccine, vol. 28, no. 17, pp. 3047–3054, 2010.
[125]  R. H. Smith, J. R. Levy, and R. M. Kotin, “A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells,” Molecular Therapy, vol. 17, no. 11, pp. 1888–1896, 2009.
[126]  A. Negrete, L. C. Yang, A. F. Mendez, J. R. Levy, and R. M. Kotin, “Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system,” Journal of Gene Medicine, vol. 9, no. 11, pp. 938–948, 2007.
[127]  H. A. Overton, Y. Fujii, I. R. Price, and I. M. Jones, “The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification of an insect cell expression system,” Virology, vol. 170, no. 1, pp. 107–116, 1989.
[128]  C. Q. Y. Zeng, M. J. Wentz, J. Cohen, M. K. Estes, and R. F. Ramig, “Characterization replicase activity of double-layered and single-layered rotavirus-like particles expressed from baculovirus recombinants,” Journal of Virology, vol. 70, no. 5, pp. 2736–2742, 1996.
[129]  J. A. Mena, O. T. Ramírez, and L. A. Palomares, “Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles,” BMC Biotechnology, vol. 7, article 39, 2007.
[130]  V. C. Emery and D. H. L. Bishop, “The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and acNPV polyhedrin protein by a recombinant baculovirus,” Protein Engineering, Design and Selection, vol. 1, no. 4, pp. 359–366, 1987.
[131]  U. Weyer and R. D. Possee, “A baculovirus dual expression vector derived from the Autographa californica nuclear polyhedrosis virus polyhedrin and p10 promoters: co-expression of two influenza virus genes in insect cells,” Journal of General Virology, vol. 72, no. 12, pp. 2967–2974, 1991.
[132]  A. S. Belyaev, “High-level expression of five foreign genes by a single recombinant baculovirus,” Gene, vol. 156, no. 2, pp. 229–233, 1995.
[133]  A. S. Belyaev and P. Roy, “Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells,” Nucleic Acids Research, vol. 21, no. 5, pp. 1219–1223, 1993.
[134]  I. Berger, D. J. Fitzgerald, and T. J. Richmond, “Baculovirus expression system for heterologous multiprotein complexes,” Nature Biotechnology, vol. 22, no. 12, pp. 1583–1587, 2004.
[135]  D. J. Fitzgerald, C. Schaffitzel, P. Berger et al., “Multiprotein expression strategy for structural biology of eukaryotic complexes,” Structure, vol. 15, no. 3, pp. 275–279, 2007.
[136]  D. J. Fitzgerald, P. Berger, C. Schaffitzel, K. Yamada, T. J. Richmond, and I. Berger, “Protein complex expression by using multigene baculoviral vectors,” Nature Methods, vol. 3, no. 12, pp. 1021–1032, 2006.
[137]  A. B. Oppenheim, A. J. Rattray, M. Bubunenko, L. C. Thomason, and D. L. Court, “In vivo recombineering of bacteriophage λ by PCR fragments and single-strand oligonucleotides,” Virology, vol. 319, no. 2, pp. 185–189, 2004.
[138]  N. G. Copeland, N. A. Jenkins, and D. L. Court, “Recombineering: a powerful new tool for mouse functional genomics,” Nature Reviews Genetics, vol. 2, no. 10, pp. 769–779, 2001.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133